Around eighty% of TTP is activated by deficient activity of ADAMTS13. ADAMTS13 deficiency can be constitutive, due to biallelic ADAMTS13 pathogenic variants; or acquired, on account of an inhibitory antibody. Analysis of ADAMTS13 activity is done utilizing exams depending on the capability in the protease to cleave common VWF multimers in vitro (e.